414 related articles for article (PubMed ID: 19553400)
41. Altered mucin gene expression in stone-containing intrahepatic bile ducts and cholangiocarcinomas.
Lee KT; Liu TS
Dig Dis Sci; 2001 Oct; 46(10):2166-72. PubMed ID: 11680592
[TBL] [Abstract][Full Text] [Related]
42. Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice.
Farazi PA; Zeisberg M; Glickman J; Zhang Y; Kalluri R; DePinho RA
Cancer Res; 2006 Jul; 66(13):6622-7. PubMed ID: 16818635
[TBL] [Abstract][Full Text] [Related]
43. Recurrent cholangiocarcinoma: negative autopsy results after aggressive management.
Ashamalla H; Kostandy G; Salama S; Ghaly M; Taha H; Toni E; Sosler B; Chandra P
South Med J; 2000 Jun; 93(6):603-5. PubMed ID: 10881779
[TBL] [Abstract][Full Text] [Related]
44. Epithelial-mesenchymal transition induced by hepatitis C virus core protein in cholangiocarcinoma.
Li T; Li D; Cheng L; Wu H; Gao Z; Liu Z; Jiang W; Gao YH; Tian F; Zhao L; Wang S
Ann Surg Oncol; 2010 Jul; 17(7):1937-44. PubMed ID: 20162464
[TBL] [Abstract][Full Text] [Related]
45. Intrahepatic cholangiocarcinoma.
Nuzzo G; Giuliante F; Ardito F; Giovannini I
Ann Surg; 2009 Mar; 249(3):541-2; author reply 542. PubMed ID: 19247046
[No Abstract] [Full Text] [Related]
46. A new mucin antibody/enzyme-linked lectin-sandwich assay of serum MUC5AC mucin for the diagnosis of cholangiocarcinoma.
Bamrungphon W; Prempracha N; Bunchu N; Rangdaeng S; Sandhu T; Srisukho S; Boonla C; Wongkham S
Cancer Lett; 2007 Mar; 247(2):301-8. PubMed ID: 16793202
[TBL] [Abstract][Full Text] [Related]
47. [Intrahepatic sarcomatoid cholangiocarcinoma with osteoclast-like giant cells: report of a case].
Fan XS; Chen J; Wu HY; Qiu YD; Zhang WW; Kong WT
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):640-1. PubMed ID: 21092600
[No Abstract] [Full Text] [Related]
48. Intrahepatic mucinous cholangiocarcinoma.
Lin BY; Wu CC; Tsai TH
Kaohsiung J Med Sci; 2020 Sep; 36(9):757-758. PubMed ID: 32492241
[No Abstract] [Full Text] [Related]
49. Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement.
Shimada K; Sano T; Nara S; Esaki M; Sakamoto Y; Kosuge T; Ojima H
Surgery; 2009 Apr; 145(4):411-6. PubMed ID: 19303990
[TBL] [Abstract][Full Text] [Related]
50. [Oncological surgery of the pancreas and bile ducts: current therapeutic prospects].
Silvestri A; Peparini N
G Chir; 2006; 27(11-12):401-4. PubMed ID: 17198547
[No Abstract] [Full Text] [Related]
51. [Indication for surgery and surgical procedure for intrahepatic cholangiocarcinoma].
Igami T; Ebata T; Nagino M
Nihon Rinsho; 2015 Mar; 73 Suppl 3():660-3. PubMed ID: 25857108
[No Abstract] [Full Text] [Related]
52. Decreased intratumoral arteries reflect portal tract destruction and aggressive characteristics in intrahepatic cholangiocarcinoma.
Aishima S; Iguchi T; Nishihara Y; Fujita N; Taguchi K; Taketomi A; Maehara Y; Tsuneyoshi M
Histopathology; 2009 Mar; 54(4):452-61. PubMed ID: 19309397
[TBL] [Abstract][Full Text] [Related]
53. [A case of mucin-producing cholangiocarcinoma with inflammatory wall thickening and reduction in size at 5 months].
Nasu Y; Kondo S; Hirano S; Shichinohe T; Nakanishi Y; Itoh T
Nihon Shokakibyo Gakkai Zasshi; 2008 Jan; 105(1):68-73. PubMed ID: 18176044
[TBL] [Abstract][Full Text] [Related]
54. Left hemihepatectomy and caudate lobectomy and complete extrahepatic bile duct resection using transduodenal approach for hilar cholangiocarcinoma arsing from biliary papillomatosis.
Kim JK; Hwang HK; Park JS; Cho SI; Yoon DS; Chi HS
J Surg Oncol; 2008 Aug; 98(2):139-42. PubMed ID: 18521837
[TBL] [Abstract][Full Text] [Related]
55. Expression of c-erbB-2 and cyclooxygenase-2 in intrahepatic cholangiocarcinoma.
Choi HJ; Kim HJ; Choi JH
Hepatogastroenterology; 2009; 56(91-92):606-9. PubMed ID: 19621664
[TBL] [Abstract][Full Text] [Related]
56. Mucin-hypersecreting cholangiocarcinoma.
Park HJ; Seo DW; Lee SK; Kim MH
Gastrointest Endosc; 2000 Oct; 52(4):526. PubMed ID: 11023572
[No Abstract] [Full Text] [Related]
57. Outcomes of surgery for 2010 WHO classification-based intraductal papillary neoplasm of the bile duct: Case-control study of a single Japanese institution's experience with special attention to mucin expression patterns.
Harada F; Matsuyama R; Mori R; Kumamoto T; Morioka D; Taguri M; Yamanaka S; Endo I
Eur J Surg Oncol; 2019 May; 45(5):761-768. PubMed ID: 30389302
[TBL] [Abstract][Full Text] [Related]
58. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct--an immunohistochemical study of 110 cases of hepatolithiasis.
Zen Y; Sasaki M; Fujii T; Chen TC; Chen MF; Yeh TS; Jan YY; Huang SF; Nimura Y; Nakanuma Y
J Hepatol; 2006 Feb; 44(2):350-8. PubMed ID: 16360234
[TBL] [Abstract][Full Text] [Related]
59. Three-dimensional printing model of liver for operative simulation in perihilar cholangiocarcinoma.
Takagi K; Nanashima A; Abo T; Arai J; Matsuo N; Fukuda T; Nagayasu T
Hepatogastroenterology; 2014; 61(136):2315-6. PubMed ID: 25699373
[TBL] [Abstract][Full Text] [Related]
60. Transplantation for cholangiocarcinoma: when and for whom?
Rea DJ; Rosen CB; Nagorney DM; Heimbach JK; Gores GJ
Surg Oncol Clin N Am; 2009 Apr; 18(2):325-37, ix. PubMed ID: 19306815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
